Shanghai Pharmaceuticals Holding Co., Ltd (HKG:2607)

HKG:2607 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	36,732	35,744	30,518	27,401	22,390	22,354
Trading Asset Securities	7,816	8,633	10,152	9,614	-	-
Cash & Short-Term Investments	44,548	44,377	40,670	37,015	22,390	22,354
Cash Growth	5.10%	9.12%	9.87%	65.32%	0.16%	22.83%
Accounts Receivable	91,517	82,217	77,163	70,187	61,006	55,522
Other Receivables	2,892	2,237	2,373	1,957	1,786	1,343
Receivables	94,409	84,454	79,536	72,144	62,791	56,865
Inventory	41,784	38,944	36,623	34,460	27,104	24,088
Other Current Assets	3,187	4,048	5,605	5,894	4,209	4,255
Total Current Assets	183,928	171,823	162,434	149,513	116,494	107,563
Property, Plant & Equipment	18,995	19,175	18,006	16,550	15,793	14,626
Long-Term Investments	8,563	9,835	10,603	11,477	10,836	7,663
Goodwill	12,736	11,146	11,393	11,336	11,239	11,342
Other Intangible Assets	8,939	5,617	6,051	6,263	6,049	5,195
Long-Term Deferred Tax Assets	1,734	1,628	1,717	1,535	1,368	1,359
Long-Term Deferred Charges	761.22	749.89	785.22	342.61	259.23	639.15
Other Long-Term Assets	1,091	1,236	983.3	1,119	1,397	797.64
Total Assets	236,746	221,209	211,973	198,135	163,436	149,186
Accounts Payable	64,548	59,483	54,632	51,566	41,995	37,792
Accrued Expenses	1,835	10,637	10,638	9,574	7,985	6,816
Short-Term Debt	44,490	44,096	41,612	33,811	31,592	25,158
Current Portion of Long-Term Debt	3,903	191.8	2,366	2,649	33.44	8,311
Current Portion of Leases	-	649.07	596.67	580.68	545.04	574.57
Current Income Taxes Payable	1,382	835.87	809.8	781.36	721.16	682.45
Current Unearned Revenue	1,305	1,562	1,971	2,243	1,311	1,311
Other Current Liabilities	21,527	8,583	9,747	9,487	7,642	7,488
Total Current Liabilities	138,990	126,038	122,372	110,691	91,824	88,133
Long-Term Debt	4,121	8,331	5,786	6,260	7,158	1,184
Long-Term Leases	1,200	1,396	1,550	1,302	1,434	1,501
Long-Term Unearned Revenue	528.97	550.99	633.48	534.58	2,349	2,224
Long-Term Deferred Tax Liabilities	1,917	816.45	1,016	1,049	998.77	832.38
Other Long-Term Liabilities	366.86	294.44	250.14	257.26	566.09	570.39
Total Liabilities	147,124	137,467	131,646	120,132	104,369	94,445
Common Stock	3,708	3,708	3,703	3,698	2,842	2,842
Additional Paid-In Capital	29,702	29,648	29,188	29,098	16,071	15,898
Retained Earnings	42,910	38,854	36,129	34,639	30,591	26,880
Comprehensive Income & Other	-537.31	-534.28	-496.09	-371.32	-144.39	-265.41
Total Common Equity	75,783	71,676	68,524	67,063	49,359	45,355
Minority Interest	13,840	12,067	11,802	10,939	9,707	9,386
Shareholders' Equity	89,623	83,742	80,326	78,002	59,066	54,741
Total Liabilities & Equity	236,746	221,209	211,973	198,135	163,436	149,186
Total Debt	53,715	54,664	51,911	44,602	40,762	36,728
Net Cash (Debt)	-9,167	-10,287	-11,241	-7,587	-18,372	-14,374
Net Cash Per Share	-2.48	-2.78	-3.04	-2.18	-6.46	-5.06
Filing Date Shares Outstanding	3,692	3,708	3,703	3,698	2,842	2,842
Total Common Shares Outstanding	3,692	3,708	3,703	3,698	2,842	2,842
Working Capital	44,938	45,785	40,062	38,822	24,670	19,430
Book Value Per Share	20.52	19.33	18.50	18.14	17.37	15.96
Tangible Book Value	54,109	54,913	51,080	49,464	32,071	28,817
Tangible Book Value Per Share	14.65	14.81	13.79	13.38	11.28	10.14
Buildings	-	13,455	10,959	10,941	9,698	9,351
Machinery	-	11,302	9,982	9,054	8,203	7,743
Construction In Progress	-	2,149	3,570	2,777	2,914	1,737

Source: S&P Global Market Intelligence. Standard template. Financial Sources.